Endocrine Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy
Conditions:   Locally Advanced Breast Cancer;   Hormone Receptor Positive，HER2-negative Breast Cancer Intervention:   Drug: letrozole Sponsors:   Yongsheng Wang;   Jiangsu HengRui Medicine Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2023 Category: Research Source Type: clinical trials